HCA Healthcare, Inc. $HCA Shares Sold by APG Asset Management N.V.

APG Asset Management N.V. lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 2.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 159,543 shares of the company’s stock after selling 4,700 shares during the period. APG Asset Management N.V. owned 0.07% of HCA Healthcare worth $67,997,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Clearstead Trust LLC lifted its position in shares of HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after acquiring an additional 53 shares in the last quarter. Harbor Capital Advisors Inc. raised its position in shares of HCA Healthcare by 82.9% in the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after buying an additional 34 shares during the last quarter. Twin Peaks Wealth Advisors LLC acquired a new position in HCA Healthcare in the 2nd quarter valued at $40,000. Compound Global Advisors LLC acquired a new position in HCA Healthcare in the third quarter valued at $44,000. Finally, True Wealth Design LLC increased its stake in shares of HCA Healthcare by 179.5% during the 3rd quarter. True Wealth Design LLC now owns 109 shares of the company’s stock valued at $47,000 after acquiring an additional 70 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently commented on HCA shares. Truist Financial upped their price target on shares of HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Argus increased their target price on HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. Sanford C. Bernstein set a $541.00 price objective on HCA Healthcare in a report on Monday, February 9th. Morgan Stanley downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 target price for the company. in a research report on Monday, December 15th. Finally, Oppenheimer boosted their price objective on shares of HCA Healthcare from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $534.50.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Analyst upgrade/price-target lift — Mizuho set a new $585 price target for HCA, reinforcing bullish analyst sentiment and helping support the stock’s rally. Read More.
• Positive Sentiment: Post‑earnings momentum — Analysts and writeups (Zacks) highlight HCA’s strong post‑earnings performance (EPS beat and raised FY26 guidance), which is a key reason for recent share gains. Read More.
• Positive Sentiment: Investor roadshow / conference calendar — HCA will present at multiple March healthcare conferences (TD Cowen, Raymond James, Barclays, Leerink, Oppenheimer), increasing institutional visibility and liquidity. Read More.
• Positive Sentiment: Expansion & facility investments — TriStar (an HCA division) is planning a $21M freestanding ER in Fairview and HCA (with Ascension) is targeting high‑growth markets with ER builds, signaling organic growth and franchise expansion. Read More.
• Positive Sentiment: Market strategy: ER build partnership — Coverage on HCA and Ascension targeting growth markets with ER builds points to disciplined capital deployment to capture patient volumes. Read More.
• Positive Sentiment: Quality recognition — A local report highlights high marks for HCA on CABG outcomes, which supports reputation and could help referrals/volume over time. Read More.
• Positive Sentiment: Brand and reputation wins — HCA and several systems made Fortune’s Most‑Admired list, a positive for reputation and hiring/partnerships. Read More.
• Neutral Sentiment: Local market developments — Coverage of Northeast Florida health‑care development (HCA, Baptist, Ascension St. Vincent’s) outlines competitive dynamics; useful for regional growth outlook but not an immediate system‑wide catalyst. Read More.
• Neutral Sentiment: New clinic opening — HCA Florida’s North Florida Hospital launched a test‑and‑treat clinic (local operational expansion), positive for access but a limited impact on consolidated results. Read More.
• Neutral Sentiment: Governance / compensation update — HCA disclosed its 2026 executive bonus plan and a longtime board member will retire; watch for details tying pay to metrics, but this is mostly governance housekeeping. Read More.
• Neutral Sentiment: Comparative performance pieces — A Yahoo Finance comparison of HCA vs. peer healthcare stocks offers context for investors but contains no new company-specific catalyst. Read More.

Insider Activity at HCA Healthcare

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the completion of the sale, the senior vice president owned 44,379 shares of the company’s stock, valued at approximately $22,411,395. The trade was a 8.27% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Jennifer Berres sold 8,020 shares of the business’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the sale, the senior vice president directly owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 15,214 shares of company stock valued at $7,797,595 in the last 90 days. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $528.69 on Monday. The firm’s fifty day moving average price is $493.99 and its 200 day moving average price is $460.92. The company has a market capitalization of $118.23 billion, a price-to-earnings ratio of 18.63, a price-to-earnings-growth ratio of 1.63 and a beta of 1.34. HCA Healthcare, Inc. has a 12-month low of $295.00 and a 12-month high of $552.90.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business had revenue of $19.51 billion for the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter in the previous year, the firm posted $6.22 earnings per share. The company’s revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a $0.78 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio is currently 10.15%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.